BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36883639)

  • 1. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
    Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
    Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autopsied case of MV2K + C-type sporadic Creutzfeldt-Jakob disease presenting with widespread cerebral cortical involvement and Kuru plaques.
    Iwasaki Y; Saito Y; Aiba I; Kobayashi A; Mimuro M; Kitamoto T; Yoshida M
    Neuropathology; 2017 Jun; 37(3):241-248. PubMed ID: 28568896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autopsy case of MV2K-type sporadic Creutzfeldt-Jakob disease presenting with characteristic clinical, radiological, and neuropathological findings.
    Matsuo K; Goto D; Hasegawa M; Ogita K; Koyama T; Akagi A; Kitamoto T; Yoshida M; Iwasaki Y
    Neuropathology; 2022 Jun; 42(3):245-253. PubMed ID: 35441383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel histotypes of sporadic Creutzfeldt-Jakob disease linked to 129MV genotype.
    Cracco L; Puoti G; Cornacchia A; Glisic K; Lee SK; Wang Z; Cohen ML; Appleby BS; Cali I
    Acta Neuropathol Commun; 2023 Aug; 11(1):141. PubMed ID: 37653534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autopsy case of MV2K-type sporadic Creutzfeldt-Jakob disease with spongiform changes of the cerebral cortex.
    Iwasaki Y; Hiraga K; Ito S; Ando T; Akagi A; Riku Y; Mimuro M; Miyahara H; Kobayashi A; Kitamoto T; Yoshida M
    Neuropathology; 2019 Dec; 39(6):452-460. PubMed ID: 31515858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
    Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
    Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein.
    Kobayashi A; Iwasaki Y; Otsuka H; Yamada M; Yoshida M; Matsuura Y; Mohri S; Kitamoto T
    Acta Neuropathol Commun; 2013 Nov; 1():74. PubMed ID: 24252157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extensive cortical spongiform changes with cerebellar small amyloid plaques: the clinicopathological case of MV2K+C subtype in Creutzfeldt-Jakob disease.
    Araki K; Nakano Y; Kobayashi A; Matsudaira T; Sugiura A; Takao M; Kitamoto T; Murayama S; Obi T
    Neuropathology; 2014 Dec; 34(6):541-6. PubMed ID: 24984899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel subtype of sporadic Creutzfeldt-Jakob disease with PRNP codon 129MM genotype and PrP plaques.
    Bayazid R; Orru' C; Aslam R; Cohen Y; Silva-Rohwer A; Lee SK; Occhipinti R; Kong Q; Shetty S; Cohen ML; Caughey B; Schonberger LB; Appleby BS; Cali I
    Acta Neuropathol; 2023 Jul; 146(1):121-143. PubMed ID: 37156880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.
    Collins SJ; Sanchez-Juan P; Masters CL; Klug GM; van Duijn C; Poleggi A; Pocchiari M; Almonti S; Cuadrado-Corrales N; de Pedro-Cuesta J; Budka H; Gelpi E; Glatzel M; Tolnay M; Hewer E; Zerr I; Heinemann U; Kretszchmar HA; Jansen GH; Olsen E; Mitrova E; Alpérovitch A; Brandel JP; Mackenzie J; Murray K; Will RG
    Brain; 2006 Sep; 129(Pt 9):2278-87. PubMed ID: 16816392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
    Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
    Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of MV2K subtype of sporadic Creutzfeldt-Jakob disease with florid-like plaques: Similarities and differences to variant Creutzfeldt-Jakob disease.
    Bošnjak M; Zupan A; Fiorini M; Popović KŠ; Popović M
    Neuropathology; 2020 Aug; 40(4):389-398. PubMed ID: 32249464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autopsy case of MV 2K + C subtype of Creutzfeldt-Jakob disease.
    Uchino A; Saito Y; Tokuda S; Saburo Y; Murayama S; Hasegawa K
    Neuropathology; 2024 Feb; ():. PubMed ID: 38353038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.
    Rossi M; Saverioni D; Di Bari M; Baiardi S; Lemstra AW; Pirisinu L; Capellari S; Rozemuller A; Nonno R; Parchi P
    Acta Neuropathol Commun; 2017 Nov; 5(1):87. PubMed ID: 29169405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
    Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
    Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autopsied case of MM1 + MM2-cortical with thalamic-type sporadic Creutzfeldt-Jakob disease presenting with hyperintensities on diffusion-weighted MRI before clinical onset.
    Iwasaki Y; Mori K; Ito M; Mimuro M; Kitamoto T; Yoshida M
    Neuropathology; 2017 Feb; 37(1):78-85. PubMed ID: 27436355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient with MV2 subtype of sporadic Creutzfeldt-Jakob disease and atypical clinical presentation.
    Guerrero D; Martínez-Velilla N; Caballero MC; Mendióroz MT; Tuñón T; Masdeu J; Rodríguez A; Armstrong J; Ferrer I
    Clin Neuropathol; 2008; 27(6):408-13. PubMed ID: 19130739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases.
    Zhang W; Orrú CD; Foutz A; Ding M; Yuan J; Shah SZA; Zhang J; Kotobelli K; Gerasimenko M; Gilliland T; Chen W; Tang M; Cohen M; Safar J; Xu B; Hong DJ; Cui L; Hughson AG; Schonberger LB; Tatsuoka C; Chen SG; Greenlee JJ; Wang Z; Appleby BS; Caughey B; Zou WQ
    Acta Neuropathol; 2024 Jan; 147(1):17. PubMed ID: 38231266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.